Table 1 Preoperative baseline data comparison between the two groups
Variable | MVI negative (n = 68) | MVI positive (n = 92) | P value |
|---|---|---|---|
Age (years) | 57.5 ± 9.4 | 54.3 ± 12.8 | 0.194 |
Gender | |||
 Female | 62 (91.2) | 72 (78.3) | 0.140 |
 Male | 6 (8.8) | 20 (21.7) |  |
HBV infection | |||
 Present | 18 (26.5) | 20 (21.7) | 0.159 |
 Absent | 50 (73.5) | 72 (78.3) |  |
Liver cirrhosis | |||
 Present | 32 (47.1) | 36 (39.1) | 0.492 |
 Absent | 36 (52.9) | 56 (60.9) |  |
Diabetes | |||
 Present | 15 (22.1) | 23 (25) | 0.605 |
 Absent | 53 (77.9) | 69 (75) |  |
Hypertension | |||
 Present | 12 (17.6) | 23 (25) | 0.288 |
 Absent | 56 (82.4) | 69 (75) |  |
Smoking | |||
 Present | 13 (19.1) | 20 (21.7) | 0.753 |
 Absent | 55 (80.9) | 72 (78.3) |  |
CEA (ng/mL) | 3.15 ± 0.89 | 3.22 ± 1.06 | 0.659 |
AFP (ng/mL) | 222.4 ± 678.7 | 1227.6 ± 3112.0 | 0.039 |
ALT (U/L) | 40.9 ± 32.1 | 54.5 ± 48.4 | 0.160 |
AST (U/L) | 49.3 ± 39.2 | 54.3 ± 45.8 | 0.685 |
TBIL (mmol/L) | 15.9 ± 7.1 | 16.7 ± 8.8 | 0.664 |
ALB (g/L) | 37.4 ± 3.6 | 38.1 ± 4.6 | 0.433 |
PT (s) | 13.5 ± 1.1 | 13.7 ± 1.0 | 0.232 |
Tumor diameter (cm) | 4.6 ± 3.2 | 5.8 ± 3.3 | 0.095 |
Number of tumors | 1.2 ± 0.3 | 1.6 ± 0.4 | 0.751 |
TNM stage | |||
 I–II | 28 (41.2) | 25 (27.8) | 0.063 |
 III–IV | 40 (58.9) | 67 (72.2) | |